Rtw Investments as of March 31, 2022
Portfolio Holdings for Rtw Investments
Rtw Investments holds 106 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Alnylam Pharmaceuticals (ALNY) | 5.7 | $275M | 1.7M | 163.29 | |
Rocket Pharmaceuticals (RCKT) | 5.2 | $251M | 16M | 15.86 | |
Thermo Fisher Scientific (TMO) | 4.6 | $220M | 373k | 590.65 | |
Ptc Therapeutics I (PTCT) | 4.0 | $195M | 5.2M | 37.31 | |
Illumina (ILMN) | 3.7 | $178M | 509k | 349.40 | |
Masimo Corporation (MASI) | 3.4 | $164M | 1.1M | 145.54 | |
Establishment Labs Holdings Ord (ESTA) | 3.2 | $156M | 2.3M | 67.39 | |
Vericel (VCEL) | 3.2 | $154M | 4.0M | 38.22 | |
Penumbra (PEN) | 3.1 | $148M | 666k | 222.13 | |
Mirati Therapeutics | 2.7 | $128M | 1.6M | 82.22 | |
Globus Med Cl A (GMED) | 2.6 | $124M | 1.7M | 73.78 | |
Tandem Diabetes Care Com New (TNDM) | 2.4 | $117M | 1.0M | 116.29 | |
Protagonist Therapeutics (PTGX) | 2.3 | $114M | 4.8M | 23.68 | |
C4 Therapeutics Com Stk (CCCC) | 2.3 | $110M | 4.5M | 24.26 | |
Axonics Modulation Technolog (AXNX) | 2.3 | $109M | 1.7M | 62.60 | |
Argenx Se Sponsored Adr (ARGX) | 2.2 | $106M | 337k | 315.31 | |
Cutera (CUTR) | 2.2 | $105M | 1.5M | 69.00 | |
Celldex Therapeutics Com New (CLDX) | 2.2 | $105M | 3.1M | 34.06 | |
Prometheus Biosciences | 2.2 | $104M | 2.8M | 37.76 | |
Ultragenyx Pharmaceutical (RARE) | 2.1 | $100M | 1.4M | 72.62 | |
Cytokinetics Com New (CYTK) | 2.0 | $94M | 2.6M | 36.81 | |
Avidity Biosciences Ord (RNA) | 1.8 | $89M | 4.8M | 18.47 | |
Fulcrum Therapeutics (FULC) | 1.8 | $85M | 3.6M | 23.65 | |
Pmv Pharmaceuticals (PMVP) | 1.7 | $81M | 3.9M | 20.82 | |
Natera (NTRA) | 1.6 | $78M | 1.9M | 40.68 | |
Stoke Therapeutics (STOK) | 1.6 | $77M | 3.6M | 21.05 | |
Relmada Therapeutics (RLMD) | 1.4 | $69M | 2.5M | 26.99 | |
Axsome Therapeutics (AXSM) | 1.4 | $67M | 1.6M | 41.39 | |
Regenxbio Inc equity us cm (RGNX) | 1.3 | $61M | 1.8M | 33.19 | |
Adicet Bio (ACET) | 1.2 | $60M | 3.0M | 19.97 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 1.2 | $56M | 1.3M | 43.88 | |
10x Genomics Cl A Com (TXG) | 1.2 | $56M | 735k | 76.07 | |
Immunocore Hldgs Ads (IMCR) | 1.2 | $56M | 1.9M | 29.90 | |
Dermtech Ord ord (DMTKQ) | 0.9 | $46M | 3.1M | 14.68 | |
Guardant Health (GH) | 0.9 | $46M | 690k | 66.24 | |
Outset Med (OM) | 0.8 | $41M | 900k | 45.40 | |
Gh Research Ordinary Shares (GHRS) | 0.8 | $40M | 2.2M | 18.29 | |
Avadel Pharmaceuticals Sponsored Adr | 0.8 | $39M | 5.7M | 6.83 | |
Quanterix Ord (QTRX) | 0.8 | $36M | 1.2M | 29.19 | |
Macrogenics (MGNX) | 0.7 | $35M | 4.0M | 8.81 | |
Tarsus Pharmaceuticals (TARS) | 0.7 | $34M | 2.0M | 16.82 | |
Jounce Therapeutics | 0.7 | $32M | 4.7M | 6.79 | |
Immunic (IMUX) | 0.6 | $31M | 2.7M | 11.30 | |
Tenaya Therapeutics (TNYA) | 0.6 | $29M | 2.5M | 11.78 | |
Milestone Pharmaceuticals (MIST) | 0.6 | $28M | 4.3M | 6.42 | |
Athira Pharma (ATHA) | 0.5 | $26M | 1.9M | 13.50 | |
Cincor Pharma | 0.5 | $24M | 1.4M | 17.54 | |
Oyster Point Pharma | 0.5 | $24M | 2.1M | 11.64 | |
Castle Biosciences (CSTL) | 0.5 | $22M | 497k | 44.86 | |
Apyx Medical Corporation (APYX) | 0.5 | $22M | 3.4M | 6.53 | |
Science 37 Holdings | 0.4 | $22M | 4.0M | 5.35 | |
Ventyx Biosciences (VTYX) | 0.4 | $21M | 1.6M | 13.57 | |
2seventy Bio Common Stock (TSVT) | 0.4 | $21M | 1.2M | 17.06 | |
Pulmonx Corp (LUNG) | 0.4 | $20M | 798k | 24.81 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.4 | $18M | 1.0M | 17.66 | |
Monte Rosa Therapeutics (GLUE) | 0.4 | $17M | 1.2M | 14.02 | |
Essa Pharma Com New (EPIX) | 0.3 | $16M | 2.6M | 6.18 | |
Iteos Therapeutics (ITOS) | 0.3 | $16M | 489k | 32.18 | |
Cytomx Therapeutics (CTMX) | 0.3 | $15M | 5.8M | 2.67 | |
Nanostring Technologies (NSTGQ) | 0.3 | $14M | 404k | 34.75 | |
Brainsway Sponsored Ads (BWAY) | 0.3 | $14M | 1.6M | 8.73 | |
Aadi Bioscience (AADI) | 0.3 | $13M | 765k | 16.97 | |
Renovacor | 0.3 | $13M | 3.0M | 4.24 | |
Tela Bio (TELA) | 0.2 | $12M | 1.0M | 11.63 | |
Sight Sciences (SGHT) | 0.2 | $12M | 997k | 11.56 | |
La Jolla Pharmaceutical Com Par $.0001 2 | 0.2 | $9.9M | 2.3M | 4.27 | |
Agenus Com New | 0.2 | $8.8M | 3.6M | 2.46 | |
Pyxis Oncology Common Stock (PYXS) | 0.2 | $8.6M | 2.1M | 4.04 | |
Exagen (XGN) | 0.2 | $8.0M | 990k | 8.03 | |
Urogen Pharma (URGN) | 0.2 | $7.5M | 858k | 8.71 | |
Nyxoah S A SHS (NYXH) | 0.1 | $6.6M | 345k | 19.14 | |
Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $6.4M | 7.0M | 0.91 | |
Landos Biopharma | 0.1 | $6.3M | 4.3M | 1.48 | |
Research Alliance Corp Ii Com Cl A | 0.1 | $6.2M | 637k | 9.76 | |
Bcls Acquisition Corp Com Cl A | 0.1 | $6.0M | 613k | 9.87 | |
Procept Biorobotics Corp (PRCT) | 0.1 | $5.6M | 161k | 34.99 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $4.9M | 500k | 9.80 | |
Summit Healthcre Acquistn Unit 06/03/2026 | 0.1 | $4.9M | 500k | 9.78 | |
Arya Sciences Acquisitn Corp Class A Ord Shs | 0.1 | $4.9M | 500k | 9.71 | |
Nautilus Biotechnology (NAUT) | 0.1 | $4.8M | 1.1M | 4.34 | |
Roivant Sciences SHS (ROIV) | 0.1 | $4.0M | 803k | 4.94 | |
Point Biopharma Global | 0.1 | $3.9M | 490k | 7.97 | |
5 01 Acquisition Corp Com Cl A | 0.1 | $3.9M | 392k | 9.85 | |
Johnson & Johnson (JNJ) | 0.1 | $3.2M | 18k | 177.25 | |
Medicus Sciences Acquisition Cl A Shs | 0.1 | $2.9M | 300k | 9.78 | |
Aslan Pharmaceuticals Ads | 0.1 | $2.9M | 3.3M | 0.90 | |
Immatics SHS (IMTX) | 0.1 | $2.8M | 350k | 7.99 | |
Genetron Hldgs Ads | 0.1 | $2.6M | 1.2M | 2.19 | |
Apellis Pharmaceuticals (APLS) | 0.1 | $2.6M | 51k | 50.81 | |
Rxsight (RXST) | 0.0 | $1.9M | 150k | 12.38 | |
Sophia Genetics Sa Ordinary Shares (SOPH) | 0.0 | $1.8M | 227k | 7.73 | |
Apollo Endosurgery | 0.0 | $1.6M | 258k | 6.05 | |
Maxcyte (MXCT) | 0.0 | $1.4M | 200k | 6.99 | |
Connect Biopharma Hldgs Ads (CNTB) | 0.0 | $1.3M | 447k | 3.02 | |
Isoplexis Corp | 0.0 | $1.3M | 365k | 3.43 | |
Miromatrix Med | 0.0 | $1.1M | 280k | 3.96 | |
Codex Dna | 0.0 | $1.1M | 200k | 5.37 | |
Avita Therapeutics (RCEL) | 0.0 | $905k | 107k | 8.48 | |
Akoya Biosciences (AKYA) | 0.0 | $854k | 78k | 10.99 | |
908 Devices (MASS) | 0.0 | $760k | 40k | 19.00 | |
Minerva Surgical | 0.0 | $747k | 166k | 4.50 | |
Singular Genomics Systems In | 0.0 | $631k | 100k | 6.31 | |
Adverum Biotechnologies | 0.0 | $293k | 224k | 1.31 | |
Zymergen | 0.0 | $202k | 70k | 2.89 | |
Renovacor *w Exp 99/99/999 | 0.0 | $109k | 350k | 0.31 | |
Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $14k | 33k | 0.42 |